Clin2
NCT05147688Possibly a fitRecruiting

Safety study of donor stem cell treatment for lung disease

Pulmonary DiseaseAsthmaChronic Obstructive Pulmonary Disease

Treatments studied

Part of Immune system & allergy, Lungs & breathing clinical trials.

This early study tests whether donor stem cells made from umbilical cord tissue are safe in people with lung diseases. If you qualify, you may be offered the study treatment while the team closely checks for side effects and safety.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
20 people
Ages
Any age
Study type
Interventional

Who can take part

  • You have been diagnosed with a lung (pulmonary) disease
  • You are able and willing to sign a written consent form
  • You do not have an active (ongoing) infection
  • You do not have cancer that is currently being treated or active
  • You are not pregnant, and you follow birth-control rules if you could become pregnant

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06491043Recruiting· Phase 2
Stem cells for COPD: safety and early effectiveness study

This trial tests whether an infusion of donor stem cells can help people with moderate to severe COPD breathe easier. If you are a current or former smoker aged 40 to 80, your symptoms are stable, and your lung function meets specific targets, you may be able to join.

New Taipei City
NCT05016817Recruiting· Phase 1
Testing an IV stem cell treatment for idiopathic pulmonary fibrosis

This Phase 1 study tests whether an IV infusion of stem cells from donated umbilical cord tissue is safe for people with idiopathic pulmonary fibrosis. It focuses mainly on safety and tolerability, and it may help by offering a new treatment approach if the cells are safe for you.

St John's
NCT05018845Recruiting· Phase 1
Testing a donated stem cell treatment for chronic kidney disease

This early study (Phase 1) tests whether an intravenously given, donated stem cell product is safe for people with chronic kidney disease. It mainly looks at side effects and whether the treatment can be given without harming you.

St John's
NCT05158127Not yet recruiting· Phase 1
Testing stem cell treatment for skin ulcers

This early-phase study tests whether lab-made stem cells from donated umbilical cord tissue are safe for treating a skin ulcer. It mainly looks at side effects and whether the treatment can be given safely.

St John's
NCT05152290Recruiting· Phase 1
Safety study of stem cell treatment for spinal cord injury

This Phase 1 study tests whether an off-the-shelf stem cell product made from donated umbilical cord tissue is safe for people with spinal cord injury. It mainly looks at side effects and safety, and may help pave the way for future effectiveness studies.

St John's
NCT05003388Recruiting· Phase 1
Safety study of IV stem cells from donor umbilical cord

This early study tests whether an IV infusion of donor-derived stem cells is safe for people with multiple sclerosis. It mainly focuses on side effects and safety, not whether it improves MS symptoms yet.

St John's

Hear when a new Pulmonary Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.